|
|
||||||||
Journal of General Virology, Vol 78, 2735-2746, Copyright © 1997 by Society for General Microbiology
ARTICLES |
ZX Zhang, M Chen, C Hultgren, A Birkett, DR Milich and M Sallberg
Division of Clinical Virology, Huddinge University Hospital, Sweden.
The interaction between the host major histocompatibility complex (MHC) and the genotype of the hepatitis C virus (HCV) was analysed using synthetic full-length non-structural (NS) 4A proteins, residues 1658- 1712, of genotypes 1b, 2b, 3a, 4a and 5a. Human and murine antibodies specific for the five NS4A genotypes analysed focused on residues 1688- 1707. In immunized B10 H-2 congenic mice, the H-2d, H-2f and H-2s haplotypes were good responders to NS4A, irrespective of the viral genotype. In contrast, the H-2k haplotype was a low or non-responder to all NS4A genotypes, except for genotype 2b. Also, H-2f- and H-2s- restricted NS4A genotype 1b-specific T-cells focused on residues 1670- 1679 and 1683-1692, respectively, whereas H-2k-restricted NS4A genotype 2b-specific T-cells focused on the carboxy terminus. Interestingly, H- 2f-restricted genotype 1b-specific T-cells did not cross-react with T- cell site analogues of seven other genotypes, whereas the H-2s- restricted, genotype 1b-specific T-cells cross-reacted with genotypes 1a, 4a and 5a. Thus the combination of viral genotype and host MHC profoundly influences the ability to mount an HCV NS4A-specific immune response.
This article has been cited by other articles:
![]() |
B. D. Lindenbach, B. M. Pragai, R. Montserret, R. K. F. Beran, A. M. Pyle, F. Penin, and C. M. Rice The C Terminus of Hepatitis C Virus NS4A Encodes an Electrostatic Switch That Regulates NS5A Hyperphosphorylation and Viral Replication J. Virol., September 1, 2007; 81(17): 8905 - 8918. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Soderholm, G Ahlen, A Kaul, L Frelin, M Alheim, C Barnfield, P Liljestrom, O Weiland, D R Milich, R Bartenschlager, et al. Relation between viral fitness and immune escape within the hepatitis C virus protease Gut, February 1, 2006; 55(2): 266 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Lazdina, C. Hultgren, L. Frelin, M. Chen, K. Lodin, O. Weiland, G. Leroux-Roels, J. A. Quiroga, D. L. Peterson, D. R. Milich, et al. Humoral and CD4+ T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein J. Gen. Virol., June 1, 2001; 82(6): 1299 - 1308. [Abstract] [Full Text] |
||||
![]() |
J. Iroegbu, M. Birk, U. Lazdina, A. Sonnerborg, and M. Sallberg Variability and Immunogenicity of Human Immunodeficiency Virus Type 1 p24 Gene Quasispecies Clin. Vaccine Immunol., May 1, 2000; 7(3): 377 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-X. Zhang, U. Lazdina, M. Chen, D. L. Peterson, and M. Sallberg Characterization of a Monoclonal Antibody and Its Single-Chain Antibody Fragment Recognizing the Nucleoside Triphosphatase/Helicase Domain of the Hepatitis C Virus Nonstructural 3 Protein Clin. Vaccine Immunol., January 1, 2000; 7(1): 58 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Devesa, A. de Saez, G. Leon, F. Sirit, C. Cosson, H. Bermudez, F. Liprandi, O. Noya, and F. H. Pujol Restricted Isotypic Antibody Reactivity to Hepatitis C Virus Synthetic Peptides in Immunocompromised Patients Clin. Vaccine Immunol., March 1, 1999; 6(2): 279 - 281. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |